Progesterone enhances cytokine-stimulated nitric oxide synthase II expression and cell death in human breast cancer cells

被引:8
作者
Bentrari, F
Arnould, L
Jackson, AP
Jeannin, JF
Pance, A
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
[2] Univ Bourgogne, Fac Med, EPHE INSERM 517, Dijon, France
[3] Ctr GF Leclerc, Dept Pathol, Dijon, France
关键词
NOSII; progesterone; transcription; breast cancer; apoptosis; nitric oxide;
D O I
10.1038/labinvest.3700267
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The presence of hormone receptors is related to survival outcome in breast cancer. Previous results from our laboratory established a correlation between the presence of nitric oxide synthase II (NOSII) and nitric oxide (NO) production with progesterone receptors in a series of human breast tumours. Furthermore, this was directly related to a lower tumour grade and a lower proliferation rate of the tumour cells. To examine these results in further detail, the effect of progesterone (Pg) and 17 beta-oestradiol (E2) on NOSII expression was analysed in the human breast cancer cell line MCF-7. By Northern blot and promoter activity, we show that a cytokine mix (TNF-alpha, IL-beta, and IFN-gamma) induces NOSII transcription after 6 h stimulation. In the absence of cytokines, neither hormone affects NOSII expression. However, Pg but not E2, enhances cytokine-induced NOSII transcription as well as NO synthesis, mainly by cooperation with gamma-interferon. The increase in NO accumulation in the media induced by addition of Pg to the cytokine treatment significantly increases cell death, mainly accounted for by apoptosis, as compared to the effect of cytokines alone. Our findings help clarify the role of steroid hormones in NOSII expression as well as the effect on cell viability and may suggest novel approaches towards hormonotherapy and the treatment of cancer.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 45 条
  • [1] ALANKO A, 1985, CANCER-AM CANCER SOC, V56, P1696, DOI 10.1002/1097-0142(19851001)56:7<1696::AID-CNCR2820560738>3.0.CO
  • [2] 2-N
  • [3] Ambs S, 1998, CANCER RES, V58, P334
  • [4] Inhibitory effects of 17β-estradiol and progesterone on ovarian carcinoma cell proliferation:: A potential role for inducible nitric oxide synthase
    Bechtel, MK
    Bonavida, B
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 82 (01) : 127 - 138
  • [5] Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter
    deVera, ME
    Shapiro, RA
    Nussler, AK
    Mudgett, JS
    Simmons, RL
    Morris, SM
    Billiar, TR
    Geller, DA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) : 1054 - 1059
  • [6] Dormond O, 2002, ANTICANCER RES, V22, P3159
  • [7] Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial
    Focan, C
    Beauduin, M
    Salamon, E
    de Greve, J
    de Wasch, G
    Lobelle, JP
    Majois, F
    Tagnon, A
    Tytgat, J
    van Belle, S
    Vandervellen, R
    Vindevoghel, A
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (01) : 1 - 8
  • [8] Förstermann U, 1998, FASEB J, V12, P773
  • [9] NITRIC-OXIDE SYNTHASE ISOZYMES - CHARACTERIZATION, PURIFICATION, MOLECULAR-CLONING, AND FUNCTIONS
    FORSTERMANN, U
    CLOSS, EI
    POLLOCK, JS
    NAKANE, M
    SCHWARZ, P
    GATH, I
    KLEINERT, H
    [J]. HYPERTENSION, 1994, 23 (06) : 1121 - 1131
  • [10] Franke HR, 2002, EUR J CANCER, V38, pS69